GSK announced on Monday that Chief Executive Emma Walmsley will step down after nine years in the role, with current Chief Commercial Officer Luke Miels set to take over on January 1. The transition marks a major shift for the UK-based drugmaker as it seeks to define its long-term growth strategy. Walmsley, who took the











